A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood
- 1 August 1997
- Vol. 80 (3) , 489-496
- https://doi.org/10.1002/(sici)1097-0142(19970801)80:3<489::aid-cncr17>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.Journal of Clinical Oncology, 1991
- Chemotherapy in RetinoblastomaJournal of Pediatric Hematology/Oncology, 1991
- Dose-intensive use of cyclophosphamide in ablation of neuroblastomaCancer, 1990
- Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolitesCancer Chemotherapy and Pharmacology, 1987
- Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)Cancer, 1984
- AUTOLOGOUS BONE MARROW RESCUE IS UNNECESSARY AFTER VERY-HIGH-DOSE CYCLOPHOSPHAMIDEThe Lancet, 1983
- High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in childrenJournal of Neurosurgery, 1981
- Cardiac changes with cyclophosphamideMedical and Pediatric Oncology, 1981
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Evaluation of a high dose cyclophosphamide regimen in childhood tumorsCancer, 1969